ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,536,000 | +90.8% | 33,156 | +0.4% | 0.02% | +91.7% |
| Q1 2019 | $805,000 | +21.4% | 33,019 | -29.0% | 0.01% | +9.1% |
| Q4 2018 | $663,000 | +19.0% | 46,504 | +26.9% | 0.01% | +37.5% |
| Q3 2018 | $557,000 | -9.7% | 36,652 | -0.3% | 0.01% | -11.1% |
| Q2 2018 | $617,000 | – | 36,779 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|